Subscribe
Business

Arizona Medicaid program limits coverage for drug

By Washington Examiner
Published
Add Washington Examiner on Google

PHOENIX (AP) — Arizona’s Medicaid program is joining some other states in limiting which patients can receive an effective but expensive new drug for hepatitis C.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.